Skip to main content
. Author manuscript; available in PMC: 2016 Oct 26.
Published in final edited form as: Vaccine. 2015 Sep 21;33(43):5845–5853. doi: 10.1016/j.vaccine.2015.08.086

Figure 2. Colloidal stability of CRX-601 with chitosan derivatives.

Figure 2

Photograph of aqueous solution of CRX-601 (1 mg/mL) incubated with the indicated chitosan derivative (5 mg/mL) in 10 mM HEPES for 24h. The picture shows MGC-CRX-601 complexes are colloidally stable whereas visible precipitation is observed with GC and CO. MGC: methylglycol chitosan; GC: glycol chitosan; CO: chitosan oligosaccharide lactate.